Search Results - Steven E. Arnold

Refine Results
  1. 1
    Repurposing Diabetes Drugs for Brain Insulin Resistance in Alzheimer Disease

    Repurposing Diabetes Drugs for Brain Insulin Resistance in Alzheimer Disease by Mark Yarchoan, Steven E. Arnold

    Published 2014
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Further Evidence of Abnormal Cytoarchitecture of the Entorhinal Cortex in Schizophrenia Using Spatial Point Pattern Analyses

    Further Evidence of Abnormal Cytoarchitecture of the Entorhinal Cortex in Schizophrenia Using Spatial Point Pattern Analyses by Steven E. Arnold, Delta D Ruscheinsky, Liying Han

    Published 1997
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Hospitalization and Cognitive Decline: Can the Nature of the Relationship Be Deciphered?

    Hospitalization and Cognitive Decline: Can the Nature of the Relationship Be Deciphered? by Sarah B. Mathews, Steven E. Arnold, C. Neill Epperson

    Published 2013
    Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    Proteomic Approaches for the Discovery of Biofluid Biomarkers of Neurodegenerative Dementias

    Proteomic Approaches for the Discovery of Biofluid Biomarkers of Neurodegenerative Dementias by Becky C. Carlyle, Bianca A. Trombetta, Steven E. Arnold

    Published 2018
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    Abnormal expression of two microtubule-associated proteins (MAP2 and MAP5) in specific subfields of the hippocampal formation in schizophrenia.

    Abnormal expression of two microtubule-associated proteins (MAP2 and MAP5) in specific subfields of the hippocampal formation in schizophrenia. by Steven E. Arnold, V M Lee, Raquel E. Gur, John Q. Trojanowski

    Published 1991
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Fuzzy Entropy Metrics for the Analysis of Biomedical Signals: Assessment and Comparison

    Fuzzy Entropy Metrics for the Analysis of Biomedical Signals: Assessment and Comparison by Hamed Azami, Peng Li, Steven E. Arnold, Javier Escudero, Anne Humeau‐Heurtier

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Cognitive and social lifestyle: links with neuropathology and cognition in late life

    Cognitive and social lifestyle: links with neuropathology and cognition in late life by David A. Bennett, Steven E. Arnold, Michael Valenzuela, Carol Brayne, Julie A. Schneider

    Published 2013
    Get full text
    Revisão
    Save to List
    Saved in:
  8. 8
    Olfaction and apathy in Alzheimer's disease, mild cognitive impairment, and healthy older adults

    Olfaction and apathy in Alzheimer's disease, mild cognitive impairment, and healthy older adults by Sarah C. Seligman, Vidyulata Kamath, Tania Giovannetti, Steven E. Arnold, Paul J. Moberg

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    The relationship between cerebral Alzheimer's disease pathology and odour identification in old age

    The relationship between cerebral Alzheimer's disease pathology and odour identification in old age by Robert S. Wilson, Steven E. Arnold, Julie A. Schneider, Yuxiao Tang, David A. Bennett

    Published 2006
    Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Familiarity-based memory as an early cognitive marker of preclinical and prodromal AD

    Familiarity-based memory as an early cognitive marker of preclinical and prodromal AD by David A. Wolk, Lauren Mancuso, Daria Kliot, Steven E. Arnold, Bradford C. Dickerson

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Cognition and Neuropathology in Aging: Multidimensional Perspectives from the Rush Religious Orders Study and Rush Memory and Aging Project

    Cognition and Neuropathology in Aging: Multidimensional Perspectives from the Rush Religious Orders Study and Rush Memory and Aging Project by Selam Negash, David A. Bennett, R. S. Wilson, Julie A. Schneider, Steven E. Arnold

    Published 2011
    Get full text
    Revisão
    Save to List
    Saved in:
  12. 12
    Initial Clinical Comparison of <sup>18</sup>F-Florbetapir and <sup>18</sup>F-FDG PET in Patients with Alzheimer Disease and Controls

    Initial Clinical Comparison of <sup>18</sup>F-Florbetapir and <sup>18</sup>F-FDG PET in Patients with Alzheimer Disease and Controls by Andrew B. Newberg, Steven E. Arnold, Nancy Wintering, Barry W. Rovner, Abass Alavi

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Quality, and not Just Quantity, of Education Accounts for Differences in Psychometric Performance between African Americans and White Non-Hispanics with Alzheimer's Disease

    Quality, and not Just Quantity, of Education Accounts for Differences in Psychometric Performance between African Americans and White Non-Hispanics with Alzheimer's Disease by Alexander L. Chin, Selam Negash, Sharon X. Xie, Steven E. Arnold, Roy H. Hamilton

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Synaptic Dysbindin-1 Reductions in Schizophrenia Occur in an Isoform-Specific Manner Indicating Their Subsynaptic Location

    Synaptic Dysbindin-1 Reductions in Schizophrenia Occur in an Isoform-Specific Manner Indicating Their Subsynaptic Location by Konrad Talbot, Natalia Louneva, Julia W. Cohen, Hala Kazi, Derek J. Blake, Steven E. Arnold

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Conscientiousness and the Incidence of Alzheimer Disease and Mild Cognitive Impairment

    Conscientiousness and the Incidence of Alzheimer Disease and Mild Cognitive Impairment by R. J. Wilson, Julie A. Schneider, Steven E. Arnold, Julia L. Bienias, David A. Bennett

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    The Expression of α-, β-, and γ-Synucleins in Olfactory Mucosa from Patients with and without Neurodegenerative Diseases

    The Expression of α-, β-, and γ-Synucleins in Olfactory Mucosa from Patients with and without Neurodegenerative Diseases by John E. Duda, Ujashi Shah, Steven E. Arnold, Virginia M.-Y. Lee, John Q. Trojanowski

    Published 1999
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Multiscale Fluctuation-Based Dispersion Entropy and Its Applications to Neurological Diseases

    Multiscale Fluctuation-Based Dispersion Entropy and Its Applications to Neurological Diseases by Hamed Azami, Steven E. Arnold, Saeid Sanei, Zhuoqing Chang, Guillermo Sapiro, Javier Escudero, Anoopum S. Gupta

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    VGF as a biomarker and therapeutic target in neurodegenerative and psychiatric diseases

    VGF as a biomarker and therapeutic target in neurodegenerative and psychiatric diseases by James P. Quinn, Savannah E. Kandigian, Bianca A. Trombetta, Steven E. Arnold, Becky C. Carlyle

    Published 2021
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  19. 19
    Vascular disease and dementias: Paradigm shifts to drive research in new directions

    Vascular disease and dementias: Paradigm shifts to drive research in new directions by Mitchel A. Kling, John Q. Trojanowski, David A. Wolk, Virginia M.‐Y. Lee, Steven E. Arnold

    Published 2012
    Get full text
    Revisão
    Save to List
    Saved in:
  20. 20
    Amyloid imaging in Alzheimer's disease: comparison of florbetapir and Pittsburgh compound-B positron emission tomography

    Amyloid imaging in Alzheimer's disease: comparison of florbetapir and Pittsburgh compound-B positron emission tomography by David A. Wolk, Zheng Zhang, Sanaa Boudhar, Christopher M. Clark, Michael J. Pontecorvo, Steven E. Arnold

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: